Cancer vaccines.
Dalgleish
A G
AG
Department of Cellular and Molecular Sciences, St George's Hospital Medical School, Tooting, London, UK.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000276:immunology; D000951:Antigens, Neoplasm / Q000627:therapeutic use; D001500:BCG Vaccine / Q000276:immunology; D001424:Bacterial Infections / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015316:Genetic Therapy; D006801:Humans; D007108:Immune Tolerance; D007111:Immunity, Cellular / Q000276:immunology; D009365:Neoplasm Regression, Spontaneous / Q000276:immunology; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D014407:Tumor Cells, Cultured / Q000276:immunology / Q000637:transplantation
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D019496:Cancer Vaccines